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Purpose: The purpose of this study was to compare the results of carotid endarterectomy 
(CEA) in a young population with premature atherosclerosis with the results of an older 
control group, examining perioperative morbidity and mortality data, recurrent stenosis 
and symptoms, late stroke, and survival data. 
Methods" We retrospectävely studied 26 patients less than 50 years old (mean, 43.2 - 3.8 
years) and 30 patients greater than 55 years old (mean, 69.1 +- 7.4 years) who underwent 
CEA during the same time period. Data were obtained regarding demographics, athero- 
sclerotic risk factors, indication for CEA, perioperative complications, recurrent stenosis 
and symptoms, late stroke, and survival. 
Results: Smoking was more prevalent among young patients who underwent CEA (92% 
vs 70%; p = 0.036). Young patients were also more likely to be symptomatic at 
presentation (92% vs 57%; p = 0.003). The perioperative mortality rate (0% vs 0%) and 
neurologic morbidity rate (0% vs 3%; p = 1.000) were low for the study patients. During 
a mean follow-up of 67 - 42.7 months, there was no significant difference in survival rate 
(5-year survival rate, 93% vs 81%; p = 0.373), rate of late ipsilateral (4% vs 3%) and 
contralateral (4% vs 3%) stroke, restenosis and occlusion (26.9% vs 14.3%), recurrent 
symptoms (22% vs 17%), reoperation (11.5% vs 5.7%), or contralateral disease (17% vs 
23%) development that required surgery for the study or the control cohorts. 
Conclusions: Our data show that there is a high incidence of smoking and symptomatic 
presentation among young patients in whom carotid occlusive disease develops. CEA may 
be performed in young patients with low perioperative morbidity and mortality rates. 
Recurrent disease, late stroke, and survival rates are not significantly different han for 
older patients. Follow-up with serial duplex ultrasound and reoperation for symptomatic 
and high-grade asymptomatic restenosis may decrease the risk oflate stroke. (J Vasc Surg 
1997;26:447-55.) 
Rccent multicenter trials (NASCET and 
ACAS) 1,2 have established that carotid endarterec- 
tomy (CEA) is superior to medical treatment in the 
prevention of strokes. Although cerebrovascular dis- 
ease generally affects patients in their seventh and 
eighth decades of life, a population has been identi- 
fied that is affected by the premature development of
atherosclerosis and carotid occlusive disease. This 
premature form of atherosclerosis is uncommon and 
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may bc morc virulent and diffuse than that seen in 
older populations. Series report decreased longevi- 
ty 3,4 and increased risk for recurrent disease s,6 after 
surgery for this younger population. In this study, we 
reviewed our 15-year experience with CEA in pa- 
tients less than 50 years old and compared results for 
recurrent disease, late stroke, and survival with re- 
sults for older patients who underwent CEA. 
PAT IENTS AND METHODS 
We retrospectively reviewed the records of pa- 
tients less than 50 years old with carotid occlusive 
disease who underwent CEA by our practice from 
1981 to 1996. CEA was performed in 4091 patients 
of all ages during this period. Twenty-six patients 
(0.6%) less than 50 years old underwent 33 primary 
CEAs, including staged bilateral CEAs in three pa- 
fients and eventual conträlateral CEA in fonr pa- 
tients. In addition, three pafients underwent second- 
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Table I, Demographics, risk factors, and 
neurologic presentation 
Patients Control 
(n = 26) (n = 30) p 
Mean age (yr) 43.2 + 3.8 69.1 + 7.4 
Female 11 (42%) 17 (57%) 0.284 
Neurologic presentation 
Symptomatic 24 (92%) 17 (57%) 0.003 
TIA 18 (69%) 15 (50%) 0.145 
CVA 6 (23%) 2 (7%) 0.080 
Risk factors 
Smoking 24 (92%) 21 (70%) 0.036 
Hypertension 13 (50%) 21 (70%) 0.126 
Hyperlipidemia 8 (31%) 6 (20%) 0.353 
Diabetes 5 (19%) 6 (20%) 0.942 
CAD 8 (31%) 15 (50%) 0.246 
TIA, Transient ischemic attack; CVA, cerebrovascular accident; 
CAD, coronary artery disease. 
ary procedures for recurrent carotid stenosis during 
the study period. Hospital and outpatient records 
were reviewed to obtain demographics and informa- 
tion concerning risk factors for atherosclerosis, neu- 
rologic presentation, preoperative radiologic evalua- 
tion, operative technique, and postoperative course, 
including additional operations. 
Data concerning long-term outcome after CEA 
were obtained from hospital and outpatient records 
and by phone survey. After the operation, all patients 
were followed-up with routine outpatient examina- 
tions and duplex ultrasound (DUS) surveillance. In 
general, clinical follow-up was performed at 6-month 
intervals, with DUS obtained at 6 and 12 months 
after the operation and then yearly if patients were 
asymptomatic and there was no evidence of signifi- 
cant restenosis. Carotid stenosis was determined us- 
ing standardized velocity criteria. Restenosis (lumi- 
nal diameter reduction) <40% was considered mild, 
restenosis of 40% to 69% was considered moderate 
(significant), and restenosis ->70% was considered 
high-grade. Patients who had recurrent neurologic 
symptoms or evidence of high-grade restenosis by 
DUS were studied with cerebral arteriography. 
For comparison, a control group of 30 patients 
aged 55 and older (age 55 to 78 years; mean, 69.1 _+ 
7.4 years) were ranclomly selected from the group of 
4091 patients who underwent CEA during the study 
period. Patients aged 50 to 54 years were excluded to 
avoid age overlap. This control group underwent 39 
CEAs, performed by the same surgeons, during the 
same 15-year study interval. In this cohort, two pa- 
tients underwent staged bilateral CEAs and seven 
paticnts underwent eventual contralateral CEAs. 
Follow-up for this cohort was performed similar to 
the study group, with routine clinical examinations at 
6-month intervals and DUS at 6 and 12 months. 
Categorical or discreet count comparison was 
performed with generation of frequency tables, and 
Fisher's exact est was reported. Continuous variable 
comparisons were evaluated with the Wilcoxon rank- 
sum test. Survival and time-to-event data were ana- 
lyzed using the Wilcoxon test. Results were consid- 
ered significant if the p value was less than 0.05. 
RESULTS 
Preoperative r sults. There were 15 men (58%) 
and 11 women (42%) in the study group, with a 
mean age of 43.2 + 3.8 years (range, 33 to 49 years) 
at the time ofprimary CEA (Table I). Four patients 
(16%) were less than 40 years old. The mean age of 
the control group was 69.1 + 7.4 years (fange, 55 to 
78 years), with 13 men (43%). Twenty-four of the 
study patients had neurologic symptoms (92% vs 
57%; p = 0.003). Demographics, atherosclerotic r sk 
factors and comorbidities, and neurologic presenta- 
tion for study and control patients are presented in 
Table I. There was a significantly higher incidence of 
tobacco abuse (92% vs 70%; p = 0.036) among study 
patients. 
Perioperative results. All procedures for study 
and control patients were performed under general 
endotracheal nesthesia. Carotid shunting was per- 
formed in 31 of 33 CEAs (94% vs 100%), and Da- 
cron patch angioplasty was performed for all primary 
CEAs (100% vs 94%) in the study group. There were 
no perioperative (30 days) deaths (0% vs 0%) and no 
strokes (0% vs 3%; p = 1.000) among patients in the 
study group. There were two perioperative complica- 
tions (8% vs 3%; p = 0.592) of cardiac origin in the 
study group. The three study patients who under- 
weht secondary procedures for recurrent disease had 
no postoperative d aths, neurologic events, or other 
complications. 
Late results. Long-term follow-up was available 
for 23 of 2ö study patients (89% vs 100%), with a 
mean follow-up of 67.4 + 42.7 months (range, 9 to 
143 months), including all patien ts who underwent 
secondary procedures (Table II). The mean fol- 
low-up for the control group was 57.2 + 41.5 
months (range, 22 to 164 months). Radiographic 
follow-up with DUS or angiography was available for 
26 of 33 (79% vs 90%) of the primary CEAs, with a 
mean follow-up of 45.2 + 43.5 months (range, 2 to 
118 months), and for all three patients who under- 
went secondary procedures, with a mean follow-up 
of 30.3 months (range, 8 to 74 months). For control 
patients, the mean DUS follow-up was 40.9 + 38.0 
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months (range, 5 to 133 months). There was no 
significant difference in clinical or radiographic fol- 
low-up for the study and control groups. 
Two late deaths (9% vs 20%; p = 0.441) occurred 
from cerebrovascular accident and myocardial infarc- 
tion in the study group. Life table analysis (Fig. 1) 
revealed no significant difference in the 5-year sur- 
vival rate for young patients compared with control 
patients (93% vs 81%; p = 0.373). However, com- 
pared with an age-matched general population, the 
survival rate for the study group was decreased. 
A late ipsilateral stroke occurred in one study 
patient (4% vs 3%; p = 1.000) after carotid occlusion 
27 months after staged bilateral carotid repairs. In 
addition, one patient (4% vs 3%; p = 1.000) had a 
cerebrovascular ccident contralateral to the endar- 
terectomized vessel at 34 months. Five study patients 
(22% vs 17%; p = 0.730) experienced recurrent ipsi- 
lateral transient ischemic attacks at a mean of 55.5 _+ 
24.9 months (range, 28 to I00 months) after CEA. 
DUS revealed moderate restenosis in two of these 
patients, and their symptoms resolved with medical 
management. Symptoms deve!oped in the remaining 
three patients over a mean period of 40.7 -+ 21.8 
months (range, 16 to 69 months) after the primary 
CEA. All three patients (11.5% vs 5.7%; p = 0.665) 
had angiographically proved high-grade restenosis 
and under~vent a secondary procedure of carotid 
resection and polytetrafluoroethylene (PTFE) inter- 
position grafting. After the secondary procedures, 
there were no recurrent neurologic symptoms at a 
mean follow-up of 42 _+ 22.6 months (range, 27 to 
74 months) and no significant restenoses by DUS at 
a mean follow-up of 30.3 months (range, 8 to 74 
months). Life table analysis (Fig. 2) showed no sig- 
nificant difference in ipsilateral symptom-free survival 
for study patients compared with control patients 
(5-year, 74% vs. 65%; p = 0.736). 
Four (17% vs 10%; p = 0.083) study patients had 
contralateral transient ischemic attacks at a mean of 
28.2 -+ 15.1 months (range, 8 to 48 months) after 
the primary CEA. Three of these patients had signif- 
icant stenosis by DUS and angiography. Postopera- 
tive surveillance revealed one additional asymptomatic, 
high-grade contralateral stenosis. CEA was per- 
formed for these four patients. Clinical and radjo- 
graphic follow-up was available for three of the four 
patients, revealing no recurrent symptoms and one 
moderate (40% to 70%) restenosis at 18 months for 
one patient. 
Restenosis. DUS for the 26 carotid arteries in 
the study group showed moderate restenosis (40% to 
70%) in two vessels (7.7% vs 2.9%; p = 0.388), 
Table II. Late deaths, strokes, and 
recurrent disease 
Patients Control 
(n = 23) (n = 30) p 
Mean follow-up (mo) 67.4 -+ 42.7 57.2 -- 41.5 0.315 
Death 2 (9%) 6 (20%) 0.441 
CVA 
Ipsilateral 1 (4%) 1 (3%) 0.848 
Contralateral 1 (4%) 1 (3%) 0.848 
Recurrent symptoms 5 (22%) 5 (17%) 0.730 
Contralateral 4 (17%) 3 (10%) 0.451 
symptoms 
Reoperation 3 (13%) 2 (6%) 0.655 
Contralateral CEA 4 (17%) 7 (23%) 1.000 
CVA, Cerebrovascular accident. 
significant restenosis (>70%) in three vessels (11.5% 
vs 5.7%; p = 0.412), and a total occlusion in two 
vessels (7 .7% vs 5.7%; p = 0.758) at a mean fol- 
low-up time of 45.2 _+ 43.5 months (Table III). The 
five recurrent stenoses >40% in the study patients 
were detected at a mean of 33.2 +_ 13.4 months 
(range, 18 to 57 months), and the two occlusions 
were discovered at 34 and 142 months. Life table 
analysis (Fig. 3) revealed no significant difference in 
stenosis-free survival for study patients versus control 
patients (5-year, 66% vs 60%; p = 0.378). Compari- 
son of the six study patients who had seven recurrent 
stenoses or occlusions with the 17 patients who were 
without restenoses (Table IV) revealed no significant 
difference in the incidence of smoking, hypertension, 
hyperlipidemia, diabetes, coronary artery disease, 
and female gender. 
DISCUSSION 
Atherosclerotic carotid occlusive disease in 
younger patients is uncommon, and few studies have 
addressed the efficacy of CEA for the prevention of 
stroke in this population. Some investigators have 
proposed that the atherosclerotic process seen in 
these younger patients is more virulent and ditfuse 
than that seen in older populations, with earlier on- 
set, accelerated progression, and higher incidence of 
recurrent disease after surgical treatment. A higher 
recurrence rate is well documented for lower extrem- 
ity occlusive disease in younger patients, with higher 
failure rates for limb salvage, s-7 In the few studies 
that addressed CEA in the young, 3,4,8,9 recurrent 
disease of the carotid artery also is quite common. 
The cause of premature atherosclerosis is not 
clearly understood but is probably multifactorial in 
cause. Hypercoagulable states and metabolic abnor- 
malities have been implicated as possible predispos- 
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Fig. 1. Kaplan-Meier curves demonstrate survival rates for younger study group patients (T) 
compared with older control group patients (C) and expected survival rates for a 43-year-old 
general population. 27
ing factors) °,la In addition, clinical risk factors have 
been idenfified that are associated with the develop- 
ment of atherosclerosis. Smoking, hypertension, dia- 
betes, and hyperlipidemia are factors most orten im- 
plicated. In this series a significantly higher incidence 
of smoking (92% vs 70%; p = 0.036) and a trend 
towards a higher incidence of hyperlipidemia (31% vs 
20%; p = 0.353) were noted among study patients 
compared with control patients. Evans et al? noted 
similar results, finding a significantly higher rate of 
smoking (91% vs 51%) and hypertension (63% vs 
54%) among younger patients. 
Young patients with carotid disease were more 
likely to be symptomatic atpresentation i  this series 
(92% vs 55%; p = 0.003) with a marked, but not 
statistically significant, difference in the number (23% 
vs 7%; p = 0.080) who had cerebrovascular accidents 
before presentation. In a review that compared 42 
young patients less than 50 years old with 110 older 
patients, Valentine et al. 4 also found a significantly 
higher rate of presenting symptoms in younger pa- 
tients (96% vs 79%). Higher rates of symptomatic 
presentation i the young may be related to a lower 
suspicion of carotid disease and search for asymp- 
tomatic bruits or may be a reflection of the more 
aggressive atherosclerotic process seen in these pa- 
tients. 
Data from this series and others 4 suggest hat 
CEA may be performed safely in this population. In 
this series, there were no perioperative deaths or 
strokes in the group ofyoung patients. These results 
are comparable with or superior,to those for older 
patients, in whom the perioperative mortality rate 
ranges from 0% to 3% 12-14 and perioperative stroke 
occurs in 1% to 4%. 12,14 In addition, the rate of 
perioperative complications was low, with cardiac 
events accounting for the few complications seen. 
The late mortality rate for the study group (9%) 
was favorable compared with that of the control 
group (20%) and with that of other seiles of older 
patients. 15 The difference in the survival rate between 
young and old patients in this study at 5 years (93% 
vs 81%) was not statistically significant. Valentine et 
al. 4 also found nostatistically significant difference in 
the 5-year survival rate among young (83%) and 
older (67%) patients after CEA. Although the sur- 
vival rate for these younger patients is comparable 
with or better than that for older patients who un- 
dergo CEA, it is poor compared with the general 
age-matched population without atherosclerosis, as
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Fig. 2. Kaplan-Meier curvcs d¢monstrat¢ symptom-ffee survival rates for younger study group 
pati¢nts (T) compared with older control group pati¢nts (C). 
demonstrated in Fig. 1. Evans et al. 3 demonstrated 
similarly that in patients with premature atheroscle- 
rosis who undergo surgery, the survival rate was 
equivalent to the general population through 5 years, 
hut thät by 7 years the survival rate was decreased 
(79.6% vs 96.4%). The causes of late death in our 
seiles, myocardial infarction and stroke, area reflec- 
tion of the diffuse vascular disease seen in these pa- 
tients. Most series of CEA list cardiac events as the 
leading cause of late death? 2 Cardiac disease is also 
prevälent in these younger patients with premature 
atherosclerosis (20% to 43%) 3,4,7,1° and is a major 
source of late death. 
The late stroke rate was comparable for young 
(4% ipsilateral, 4% contralateral) and older patients 
(3% ipsilateral, 3% contralateral). The mean fol- 
low-up of 67 months for the study group revealed a
total late stroke incidence of 8%, with an annual 
stroke rate of 1.4%. This does not differ significantly 
from the long-term total stroke incidence of 4.7% to 
9% in series ofolder patients, with annual stroke rates 
of 1.0% to 1.75%. 12,la,is The late stroke rate in this 
seiles may have been affected by postoperative sur- 
veillance and reoperation for those patäents in whom 
significant symptomatic restenosis developed. Three 
patients with recurrent symptoms and high-grade 
restenosis underwent secondary procedures and re- 
Table II I . Restenosis 
Patients Control 
(n = 26) (n = 38) p 
Total 7 (26.7%) 5 (14.3%) 0.219 
40% to 70% 2 (7.7%) 1 (2.9%) 0.570 
>70% 3 (11.5%) 2 (5.7%) 0.655 
Occluded 2 (7.7%) 2 (5.7%) 1.000 
Symptomatic 3 (11.5%) 2 (5.7%) 0.642 
mained without stroke. However, in two patients 
who had late carotid occlusion and stroke at 34 
months and 12 years after CEA, DUS surveillance 
had been discontinued after normal scans at 12 and 
15 months after endarterectomy. Both of these pa- 
tients had remained neurologically asymptomatic, 
with no indication of progressive disease. 
The incidence of late recurrent transient ischemic 
attacks in this seiles ofyoung patients was also com- 
parable with that of the control cohort (22% vs 17%). 
In contrast, Valentine et al.4 found a significantly 
higher rate of late recurrent neurologic (transient 
and permanent) symptoms in younger patients com- 
pared with older control patients (14% vs 0.9%; p = 
0.002). It is noted that the incidence of recurrent 
symptoms in the older control cohort in our seiles 
was high compared with that in most series. 12,13 This 
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patients (Y) compared with older control group patients (C). 
Table l-V. Risk factors for restenosis 
Restenosis No resrenosis 
(n=ö) (n=17) p 
Smoldng 100% 86% 1.000 
Hypertension 83% 36% 0.141 
Hyperlipidemia 33% 21% 0.613 
Diabetes 17% 21% 1.000 
Coronary disease 50% 29% 0.613 
Female 67% 36% 0.336 
higher ate ofrecurrent symptoms seen in the control 
population may be a reflection of diffuse disease with 
intracranial atherosclerosis or may be related to the 
small sample size. 
There was a higher rate of restenosis and occlu- 
sion among younger patients in our series (26.9% vs 
14.3%; p = 0.219), but this did not reach statistical 
significance, possibly a result of  the small study size. 
Others have shown that patients who have premature 
carotid disease are athigher risk for recurrent steno- 
sis. 4,8,9 The incidence of restenosis in larger series of 
patients (1.5% to  32%) 16-22 varies depending on the 
method of detection. However, reoperation rates 
(1% tO 4%),  16=23 generally parallel rates of recurrent 
neurologic symptoms. The rate of symptomatic re- 
stenosis (not including occlusions and strokes) in our 
series o fyoung patients was three of 23 (11.5% vs 
5.7%), whereas the rate of radiographic restenosis 
was five of 26 vessels (19% vs 9%). The high preva- 
lence of symptomatic restenosis among young pa- 
tients in this series led to the high rate ofreoperation 
(11.5% vs 5.7%). Other investigators have reported 
higher rates of reoperation among young patients 
(6% to 7%) compared with older control groups 3,4 
and have noted also a-higher rate of contralateral 
diseasc development that requires surgery among 
young patients. 
The pathogenesis of carotid restenosis is un- 
known, and multiple factors may be cited as contrib- 
uting causcs. Biologic factors associated with reste- 
nosis, including female gender, 9,22,24,2~ continued 
smoking after primary CEA, 9 and hyperlipid- 
emia16 ,17,26 were prevalent in our series and may have 
contributed to the high rate of restenosis. Although 
women comprised only 42% of our study population, 
they accounted for 75% (three offour patients) of the 
recurrent lesions. In addition, all four patients with 
restenosis in our series continued to smoke after 
endarterectomy, and half had hyperlipidemia. 
The management of recurrent lesions is contro- 
versial because their significan« is unclear. 22 The 
relation between restenosis and recurrent symptoms 
is not direct. Late (>24 months) recurrent lesions, 
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particularly when symptomatic, are likely to repre- 
sent recurrent atherosclerotic disease and should be 
treated aggressively. Earlier asymptomatic lesions are 
more likely to represent myointimal hyperplasia, nd 
as many as 20% to 40% of these lesions will re- 
gress. 19,22 In our seiles, the mean time to develop- 
ment of the five restenoses and two occlusions in the 
study group was 44.6 months, with only one reste- 
nosis occurilng within 24 months of CEA. Recurrent 
lesions that were symptomatic and high-grade un- 
derwent reoperation, with patients remaining with- 
out stroke. Moderate restenoses were early and 
asymptomatic, consistent with hyperplasia, nd were 
treated medically, also without neurologic sequelae. 
The choice of operation for recurrent stenosis 
generally includes patch angioplasty, with or without 
endarterectomy, or interposition grafting for cases in 
which the vessel wall is inadequate for repeat endar- 
terectomy or patch angioplasty. In this seiles, the 
secondary procedure in all cases was carotid resection 
and PTFE interposition grafting. The patency rate of 
PTFE interposifion grafts is good in our expeilence. 
There were no symptom recurrences and no signifi- 
cant restenoses for the three patients in this seiles, 
who had a mean radiographic follow-up of 31 
months .  
CONCLUSION 
The results of our study suggest that CEA can be 
performed with a low perioperative morbidity and 
mortality rate in patients who have premature devel- 
opment of carotid occlusiv'e disease. These patients 
are frequently smokers and are symptomatic atpre- 
sentation. However, the rate of recurrent stenosis 
and symptoms, late stroke, and .survival is not signif- 
icantly different than for older patients who undergo 
CEA. Aggressive follow-up with seilal DUS surveil- 
lance for recurrent stenosis and reoperation for sig- 
nificant (>50%) symptomatic restenosis or high- 
grade asymptomatic restenosis may result in an 
acceptable ate stroke rate in these patients who have 
aggressive atherosclerotic disease. 
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DISCUSSION 
Dr. David Rosenthal (Atlanta, Ga.). I would like to 
congratulate Dr. Martin on his presentation, which I un- 
derstand is his first at the SAVS and we trust not his last. 
We have just heard an excellent analysis on a difficult subset 
of patients, those 50 years and younger, who taust un- 
dergo CEA. When the Baylor group reports on a 15-year 
experience, we should all pay attention. It is easy for me to 
comment on this paper, as I basically agree with everything 
he just said. I therefore only have an anecdotal observation 
and a few questions. Despite the excellent perioperative 
morbidity results just presented, I would like to admonish 
all of us who operate on younger patients to beware of the 
so-called young carotid vessels. In these pauents, in my 
experience, it is often difficult to obtain a good endarterec- 
tomy plane, which can make the distal end point treacher- 
ous. I am not sure whether anyone has the answer as to 
why this is so, but for lack of a bettet erm, I would call it 
immaturity of the plaque, which is often soft and fibrous 
without calcification. I do not routinely patch carotid ar- 
teries, but I agree with and would advocate patch angio- 
plasty in these younger patients and certainly women with 
inherenüy smaller vessels. 
My questions have to do with the postoperative man- 
agement of these patients. Despite the statistical compari- 
son with your control group, if my addition is correct, 
almost half of these young patients either had an ipsilateral 
or contralateral transient ischemic attack, had ä stroke, 
died, or had severe carotid disease during follow-up. This 
may not be statistically significant, which I anticipate is a 
result of the small study size, hut if I were 45 years old I 
would find this prognosis frightening. Because we know 
these patients have an aggressive form of atherosclerosis, 
how should we be monitoring their cerebrovascular and 
coronary status? Is postoperative aspirin enough or should 
we consider the use ofticlopidine or warfarin in this patient 
population? 
Your presentation and manuscilpt were excellent. I 
would finally comment that, in my opinion, 50 years old is 
äwfully young. 
Dr. Gordon H. Martin. Thank you very rauch, Dr. 
Rosenthal. I appreciate your review and your comments. 
First of all, in terms of the question about how to fol- 
low-up these patients that have very virulent and acceler- 
ated atherosclerosis, in terms of their cerebrovascular sta- 
res, given the results ofour study and studies performed by 
other investigators, we believe these patients hould un- 
dergo routine duplex scans probably every ó months for 
the first year, and if they prove to have no evidence of 
restenosis, just once a year after that. 
In regards to how to follow them from a coronary 
standpoint, I think this seiles as weil as others have shown 
that many of these patients are at high risk for coronary 
disease. Many have had previous myocardial infarctions, 
and the remainder a e at high risk for future cardiac events. 
I think in evaluating these patients for surgery, we should 
be very aggressive about worldng up their cardiac status, 
whether it be with a stress thallium or a stress echo study, 
to get a baseline for their cardiac status. 
The last question had to do with how to manage them 
from a medical standpoint in terms ofwhether aspirin was 
enough or should we use other agents. In our experience, 
ticlopidine has been met with some complications. These 
patients have a very high tendency to bleed if they are 
treated with ticlopidine. They are also at risk for the com- 
plications of neutropenia, nd so our feeling is that aspirin 
is sufficient reatment for these patients. In terms ofwarfa- 
rin treatment, we believe that the protective benefit from 
warfarin would probably require a life-long treatment. As 
such, that would put these patients at the risk of anticoag- 
ulation over many, many years. Again, I do not think 
warfarin would be necessary for these patients either. Cur- 
rently, we are treating all of these patients with aspirin 
alone. Hopefully, more effective altematives will be avail- 
able in the future. 
Dr. Paul IL Liebman (West Palm Beach, Fla.). I am 
concerned about putting PTFE in the neck in these young 
people. The concern would be using a prosthetic in a 
patient who is hopefully going to be around considerably 
longer than some of our older patients who have carotid 
disease. What are the thoughts ofyour group considering 
the use ofvein in this circumstance? 
Dr. Martin. We have used PTFE fairly offen. In this 
series we used it three times, and we are currenfly working 
on another eport of approximately 30 patients who were 
also treated with PTFE interposition grafts, and we had no 
complications among those patients with late infectious 
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problems of patency. Vein interposition grafts havc been 
shown to be very effective, as well. We have used those 
from time to time, as weil. There appears to be no clear 
superiority with Vein versus PTFE. PTFE is an acceptable 
alternative in our experience. 
Dr. James Haynes (Columbia, S.C.). We have had 
interest in lower extremity atherosclerosis and ischemic 
disease in young patients. We discovered the elevated num- 
ber of these patients with hypercoagulation problems. I 
rise to ask you two questions. First, when you looked at 
these patients, did you really study the coagulation factors, 
particularly the thrombolytic activity, as weil as the locked 
protein A, in these people? Wc have secn very few people 
with carotid artery disease in the younger patient popula- 
tion, so I congrätulate you on this presentation. As for the 
second question, have you looked at the lower extremity 
disease in the same group of patients, those who have had 
the carotid stenosis at less than 50 years of age? 
Dr. Martin. We did not specifically look at hyperco- 
agulable states in these patients in terms of measuring 
protein C, protein S, antithrombin III, and so forth, but I 
think the series by Dr. Levy and others have shown that 
there is a very high incidence of hypercoagulable states in 
these patients; as many as 90% ofthem may have some type 
of detectable defect in their coagulation system. In regards 
to lower extremities, approximately 50% of our younger 
patients did have a history of significant lower extremity 
peripheral vaseular disease, a very striking number as weil in 
these relatively oung patients. 
Dr. Clifford Bucldey (Temple, Tex.). I enjoyed your 
paper very much. I may have misunderstood one of the 
slides, but it looked as though you reported that 20% of the 
control patients as weil as approximately 20% of the study 
group of patients had symptomatic cerebrovascular com- 
plaints during the follow-up period. That seems high for 
the control group, in my own experience. I do not believe 
that 20% of our carotid surgery patients become symptom- 
atic in the follow-up period. That is also high as compared 
with what is reported in the literature. 
Dr. Martin. No, you understood correctly, and I 
would agree with your interpretation. I think most series 
show that the incidence oflate symptoms runs in the range 
of 1% to 6%. This result is related to the smaU sample size 
and more inn'acranial disease in these older patients. 
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